+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report by Product (Etonogestrel Implant, Levonorgestrel Implant), Distribution Channel, and Region with Growth Forecasts, 2025-2030- Product Image
Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report by Product (Etonogestrel Implant, Levonorgestrel Implant), Distribution Channel, and Region with Growth Forecasts, 2025-2030- Product Image
New

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report by Product (Etonogestrel Implant, Levonorgestrel Implant), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 80 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6009751
Description Jump to:
The Subdermal Contraceptive Implants Market was valued at USD 1.12 billion in 2024, and is projected to reach USD 1.74 billion by 2030, rising at a CAGR of 7.61%. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.

According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.

Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.

Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.

Subdermal Contraceptive Implants Market Report Highlights

  • Etonogestrel implants dominated the market and accounted for a share of 64.73% in 2024. The driving factors are rising unintended pregnancies and unsafe abortions.
  • Hospital dominated the market and accounted for a share of 54.37% in 2024. Hospitals provide a comprehensive environment for patients, offering a wide range of services including tests, consultations, and procedures, which drive segment growth.
  • North America subdermal contraceptive implants market dominated the market with a market share of 64.91% in 2024.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Secondary Sources
1.4.2. List of Primary Sources
1.4.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Distribution Channel Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Subdermal Contraceptive Implants Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Awareness of family planning
3.2.1.2. Demand for Long-Acting Reversible Contraceptives (LARCs)
3.2.1.3. Technological advancements and product improvements
3.2.2. Market Restraints Analysis
3.2.2.1. Side effects and health concerns
3.2.3. Industry Challenges and Opportunity Analysis
3.3. Subdermal Contraceptive Implants Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Subdermal Contraceptive Implants Market: Product Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Subdermal Contraceptive Implants Market: By Product, 2018 to 2030
4.4.1. Etonogestrel Implant
4.4.1.1. Etonogestrel implant market revenue estimates and forecasts, 2018-2030 (USD Million)
4.4.2. Levonorgestrel Implant
4.4.2.1. Levonorgestrel implant market revenue estimates and forecasts, 2018-2030 (USD Million)
Chapter 5. Subdermal Contraceptive Implants Market: Distribution Channel Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Distribution Channel Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Subdermal Contraceptive Implants Market: By Distribution Channel, 2018 to 2030
5.4.1. Hospital
5.4.1.1. Hospital market revenue estimates and forecasts, 2018-2030 (USD Million)
5.4.2. Gynecology Clinics
5.4.2.1. Gynecology clinics market revenue estimates and forecasts, 2018-2030 (USD Million)
5.4.3. Community Health Care Centers
5.4.3.1. Community health care centers market revenue estimates and forecasts, 2018-2030 (USD Million)
5.4.4. Others
5.4.4.1. Others market revenue estimates and forecasts, 2018-2030 (USD Million)
Chapter 6. Subdermal Contraceptive Implants Market: Regional Estimates & Trend Analysis by Region, Product
6.1. Definition and Scope
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Subdermal Contraceptive Implants Market Share, by Region, 2024 & 2030 (USD Million)
6.4. North America
6.4.1. North America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.2. U.S.
6.4.2.1. U.S. Key Country Dynamics
6.4.2.2. Regulatory Landscape/Reimbursement Scenario
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Canada
6.4.3.1. Canada Key Country Dynamics
6.4.3.2. Regulatory Landscape/Reimbursement Scenario
6.4.3.3. Competitive Insights
6.4.3.4. Canada Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Mexico Key Country Dynamics
6.4.4.2. Regulatory Landscape/Reimbursement Scenario
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Europe
6.5.1. Europe Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. UK
6.5.2.1. UK Key Country Dynamics
6.5.2.2. Regulatory Landscape/Reimbursement Scenario
6.5.2.3. Competitive Insights
6.5.2.4. U.K. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Germany
6.5.3.1. Germany Key Country Dynamics
6.5.3.2. Regulatory Landscape/Reimbursement Scenario
6.5.3.3. Competitive Insights
6.5.3.4. Germany Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. France
6.5.4.1. France Key Country Dynamics
6.5.4.2. Regulatory Landscape/Reimbursement Scenario
6.5.4.3. Competitive Insights
6.5.4.4. France Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.5. Italy
6.5.5.1. Italy Key Country Dynamics
6.5.5.2. Regulatory Landscape/Reimbursement Scenario
6.5.5.3. Competitive Insights
6.5.5.4. Italy Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. Spain
6.5.6.1. Spain Key Country Dynamics
6.5.6.2. Regulatory Landscape/Reimbursement Scenario
6.5.6.3. Competitive Insights
6.5.6.4. Spain Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Denmark Spain Key Country Dynamics
6.5.7.2. Regulatory Landscape/Reimbursement Scenario
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Sweden Key Country Dynamics
6.5.8.2. Regulatory Landscape/Reimbursement Scenario
6.5.8.3. Competitive Insights
6.5.8.4. Sweden Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.9. Norway
6.5.9.1. Norway Key Country Dynamics
6.5.9.2. Regulatory Landscape/Reimbursement Scenario
6.5.9.3. Competitive Insights
6.5.9.4. Norway Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.2. China
6.6.2.1. China Key Country Dynamics
6.6.2.2. Regulatory Landscape/Reimbursement Scenario
6.6.2.3. Competitive Insights
6.6.2.4. China Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.3. Japan
6.6.3.1. Japan Key Country Dynamics
6.6.3.2. Regulatory Landscape/Reimbursement Scenario
6.6.3.3. Competitive Insights
6.6.3.4. Japan Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.4. India
6.6.4.1. India Key Country Dynamics
6.6.4.2. Regulatory Landscape/Reimbursement Scenario
6.6.4.3. Competitive Insights
6.6.4.4. India Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.5. South Korea
6.6.5.1. South Korea Key Country Dynamics
6.6.5.2. Regulatory Landscape/Reimbursement Scenario
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.6. Australia
6.6.6.1. Australia Key Country Dynamics
6.6.6.2. Regulatory Landscape/Reimbursement Scenario
6.6.6.3. Competitive Insights
6.6.6.4. Australia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Thailand Key Country Dynamics
6.6.7.2. Regulatory Landscape/Reimbursement Scenario
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Brazil Key Country Dynamics
6.7.2.2. Regulatory Landscape/Reimbursement Scenario
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Argentina Key Country Dynamics
6.7.3.2. Regulatory Landscape/Reimbursement Scenario
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Middle East and Africa (MEA)
6.8.1. Middle East and Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. South Africa Key Country Dynamics
6.8.2.2. Regulatory Landscape/Reimbursement Scenario
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Saudi Arabia Key Country Dynamics
6.8.3.2. Regulatory Landscape/Reimbursement Scenario
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.4. UAE
6.8.4.1. UAE Key Country Dynamics
6.8.4.2. Regulatory Landscape/Reimbursement Scenario
6.8.4.3. Competitive Insights
6.8.4.4. UAE Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Kuwait Key Country Dynamics
6.8.5.2. Regulatory Landscape/Reimbursement Scenario
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.6. Company Profiles
7.6.1. Merck & Co., Inc.
7.6.1.1. Participant’s Overview
7.6.1.2. Financial Performance
7.6.1.3. Product Benchmarking
7.6.1.4. Recent Developments
7.6.2. Shanghai Dahua Pharmaceutical Co., Ltd.
7.6.2.1. Participant’s Overview
7.6.2.2. Financial Performance
7.6.2.3. Product Benchmarking
7.6.2.4. Recent Developments
7.6.3. Bayer AG
7.6.3.1. Participant’s Overview
7.6.3.2. Financial Performance
7.6.3.3. Product Benchmarking
7.6.3.4. Recent Developments
7.6.4. Baxter
7.6.4.1. Participant’s Overview
7.6.4.2. Financial Performance
7.6.4.3. Product Benchmarking
7.6.4.4. Recent Developments
7.6.5. BD
7.6.5.1. Participant’s Overview
7.6.5.2. Financial Performance
7.6.5.3. Product Benchmarking
7.6.5.4. Recent Developments
7.6.6. Gerresheimer AG
7.6.6.1. Participant’s Overview
7.6.6.2. Financial Performance
7.6.6.3. Product Benchmarking
7.6.6.4. Recent Developments
7.6.7. Pfizer, Inc.
7.6.7.1. Participant’s Overview
7.6.7.2. Financial Performance
7.6.7.3. Product Benchmarking
7.6.7.4. Recent Developments
7.6.8. Novartis AG
7.6.8.1. Participant’s Overview
7.6.8.2. Financial Performance
7.6.8.3. Product Benchmarking
7.6.8.4. Recent Developments
7.6.9. SCHOTT
7.6.9.1. Participant’s Overview
7.6.9.2. Financial Performance
7.6.9.3. Product Benchmarking
7.6.9.4. Recent Developments
7.6.10. Lilly
7.6.10.1. Participant’s Overview
7.6.10.2. Financial Performance
7.6.10.3. Product Benchmarking
7.6.10.4. Recent Developments
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 4 North America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 5 U.S. subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 6 U.S. subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 7 Canada subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 8 Canada subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 9 Mexico subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 10 Mexico subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 11 Europe subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 12 Europe subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 13 UK subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 14 UK subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 15 Germany subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 16 Germany subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 17 France subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 18 France subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 19 Italy subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 20 Italy subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 21 Spain subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 22 Spain subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 23 Denmark subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 24 Denmark subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 25 Sweden subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 26 Sweden subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 27 Norway subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 28 Norway subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 29 Asia Pacific subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 30 Asia Pacific subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 31 Japan subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 32 Japan subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 33 China subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 34 China subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 35 India subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 36 India subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 37 Australia subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 38 Australia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 39 South Korea subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 40 South Korea subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 41 Thailand subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 42 Thailand subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 43 Latin America subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 44 Latin America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 45 Brazil subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 46 Brazil subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 47 Argentina subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 48 Argentina subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 49 MEA subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 50 MEA subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 51 South Africa subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 52 South Africa subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 53 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 54 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 55 UAE subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 56 UAE subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 57 Kuwait subdermal contraceptive implants market estimates and forecasts by product, 2018-2030 (USD Million)
Table 58 Kuwait subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Subdermal contraceptive implants market segmentation
Figure 2 Information procurement
Figure 3 Data analysis models
Figure 4 Market formulation and validation
Figure 5 Data validating & publishing
Figure 6 Market snapshot
Figure 7 Segment snapshot (1/2)
Figure 8 Segment snapshot (2/2)
Figure 9 Competitive landscape snapshot
Figure 10 Subdermal contraceptive implants- market size and growth prospects (USD Million)
Figure 11 Subdermal contraceptive implants market: industry value chain analysis
Figure 12 Subdermal contraceptive implants market: market dynamics
Figure 13 Subdermal contraceptive implants market: porter’s analysis
Figure 14 Subdermal contraceptive implants market: pestel analysis
Figure 15 Subdermal contraceptive implants market share by product 2024 & 2030 (USD Million)
Figure 16 Subdermal contraceptive implants market, by product: key takeaways
Figure 17 Subdermal contraceptive implants market, by product: market share, 2024 & 2030
Figure 18 Etonogestrel implant market estimates & forecasts, 2018-2030 (USD Million)
Figure 19 Levonorgestrel implant market estimates & forecasts, 2018-2030 (USD Million)
Figure 20 Subdermal contraceptive implants market share by distribution channel 2024 & 2030 (USD Million)
Figure 21 Subdermal contraceptive implants market, by distribution channel: key takeaways
Figure 22 Subdermal contraceptive implants market, by distribution channel: market share, 2024 & 2030
Figure 23 Hospital market estimates & forecasts, 2018-2030 (USD Million)
Figure 24 Gynecology clinics market estimates & forecasts, 2018-2030 (USD Million)
Figure 25 Community health care centres market estimates & forecasts, 2018-2030 (USD Million)
Figure 26 Others market estimates & forecasts, 2018-2030 (USD Million)
Figure 27 Subdermal contraceptive implants market revenue, by region, 2024 & 2030 (USD Million)
Figure 28 Regional marketplace: key takeaways
Figure 29 Regional marketplace: key takeaways
Figure 30 North america subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 U.s. Subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Canada subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Mexico subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Europe subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Uk subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Germany subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 France subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Italy subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Spain subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Denmark subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Sweden subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Norway subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Asia pacific subdermal contraceptive implants market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Japan subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 China subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 India subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Australia subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 South korea subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Thailand subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Latin america subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Brazil subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Argentina subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Mea subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Saudi arabia subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 South africa subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Uae subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Kuwait subdermal contraceptive implants market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Key company categorization
Figure 59 Company market positioning
Figure 60 Key company market share analysis, 2024
Figure 61 Strategic framework

Companies Mentioned

The major companies profiled in this Subdermal Contraceptive Implants market report include:
  • Merck & Co., Inc.
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • Bayer AG
  • Baxter
  • BD
  • Gerresheimer AG
  • Pfizer, Inc.
  • Novartis AG
  • SCHOTT
  • Lilly

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages80
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.74 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Subdermal Contraceptive Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Subdermal Contraceptive Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report by Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), and Region with Growth Forecasts, 2025-2030 - Product Image

Contraceptive Drugs and Devices Market Size, Share & Trends Analysis Report by Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Contraceptives Market Report 2025 - Product Image

Contraceptives Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Contraceptives - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptives - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Contraceptive Implant Market

The Contraceptive Implant is a form of long-acting reversible contraception (LARC) that is inserted under the skin of a woman’s upper arm. It is a small, flexible rod that releases a hormone called progestin, which prevents pregnancy. It is a safe and effective form of contraception that can last up to three years. It is a popular choice for women who want a reliable form of contraception that does not require daily attention. The Contraceptive Implant is an important part of Women’s Health, as it provides a reliable form of contraception that is safe and effective. It is also a convenient option for women who want to avoid the hassle of taking a pill every day. Some companies in the Contraceptive Implant market include Bayer, Merck, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.